Monica N. Fornier, MD, and Robert. A Figlin, MD, discuss when to test for ESR1 mutations and how to choose among three oral SERDs in ER-positive metastatic breast cancer.
Want to know the latest news and articles posted on ONC?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: Oncologynewscentral.com